PurposeOphthalmic brachytherapy treats eye lesions by stitching plaques containing a radionuclide (e.g. Ru-106) onto the sclera. Compliance with quality assurance standards is crucial, but practical limitations complicate independent source strength measurement in clinical practice. In this article, a new prototype for acceptance testing of Ru-106 plaques is assayed to assess its suitability for a hospital's medical physics department. Methods and materialsThe system designed for Ru-106 plaque assessment includes a phantom basin fillable with water, a Si-diode for electrons coupled with an electrometer, type-dependent plaque holders and a micrometre gauge. Testing involved the measurement of three plaque types (CCA, CIB, COB) by six medical physics experts and trainees, the assessment of inter and intra-observer variability and the suitability for measurement at the reference point, 2 mm. ResultsMeasured absorbed dose rates in water at 2 mm from the plaque surface demonstrated compatibility across all testers for the three plaques. Intra and inter-observer variability was minimal (1.0% and 1.3% of the measured value, respectively), confirming system robustness in terms of operator influence. ConclusionsThe system proves suitable for Ru-106 plaque acceptance testing ensuring accurate plaque positioning and dose rate verification at 2 mm. These findings confirm its potential as a support for compliance with quality assurance standards. These results are subject to the issue of the corresponding calibration certificate for the Si-diode.
Read full abstract